United States · Funded startup

Who invested in Veana Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Kraised across 1 round since 2022, from 1 source

Latest round
Grant, $50KJan 2022
Investors
2
See who backed them

The rounds

  1. Jan 2022

Founders and team

From the SEC filings it signed: 2 on the team.

  • Emmanuel AkporiayeExecutive Officer, Directori
  • Rebecca AkporiayeExecutive Officer, Directori

On the board, as filediAndrew RayBruce RamseyerSandra Shotwell

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Veana Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

PortfoliaVC firmPer its own site

Quick answers about Veana Therapeutics

Who invested in Veana Therapeutics?

Veana Therapeutics's investors include Small Business Innovation Research and National Cancer Institute (NCI).

How much has Veana Therapeutics raised?

Veana Therapeutics has raised $50K across 1 round since 2022.

When did Veana Therapeutics last raise?

Veana Therapeutics's most recent round was a Grant of $50K in Jan 2022.

What was Veana Therapeutics's biggest round?

Its most recent round, $50K in Jan 2022, is also its largest on record.

Who backed Veana Therapeutics first?

Veana Therapeutics's first round on record, in Jan 2022, was backed by Small Business Innovation Research and National Cancer Institute (NCI).

What stage is Veana Therapeutics at?

Veana Therapeutics's latest named round is a Grant, in Jan 2022.

Where is Veana Therapeutics based?

Veana Therapeutics is based in the United States.

Companies like Veana Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.